Bausch & Lomb generic Alphagan
Executive Summary
Bausch & Lomb receives approval May 28 for generic version of Allergan's Alphagan (brimonidine ophthalmic solution .2%); marketing exclusivity will run until Sept. 20. Allergan withdrew distribution of Alphagan .2% in August 2002 following launch of Alphagan P .15%, preserved with Purite, in 2001 (1"The Pink Sheet" March 26, 2001, In Brief). Allergan claims the .15% concentration is safer. However the firm's generic division, Pacific Pharma, plans to sell a generic version of the .2% formulation...